top of page
Search

Semaglutide: A New Hope for Diabetes Management


a couple running in the park

Classified as a glucagon-like peptide-1 receptor agonist (GLP-1 RA), semaglutide is a medication that simulates the GLP-1 hormone, which is secreted in response to the consumption of food.


It has been primarily utilized for more than 15 years to control type 2 diabetes by stimulating the production of insulin and reducing blood glucose levels. In addition to these functions, GLP-1 is also involved in suppressing appetite and inducing a sense of satiety.


When paired with modifications in diet and an increase in physical activity, it can contribute to substantial weight loss, thereby decreasing the risk of conditions associated with obesity such as cancer, diabetes, and cardiovascular disease.


Many anti-obesity drugs have been formulated to suppress hunger and aid in weight loss. Yet, semaglutide stands out due to its superior mechanism of action.




While lifestyle modifications such as dietary changes and physical activity remain the cornerstone of obesity management, semaglutide serves as a potent tool in the therapeutic arsenal, depending on a person’s medical history.


Considering semaglutide as a potential treatment option?

Take the next step and consult Dr Tay to discuss if it could be the right treatment for you.

 

What are some common GLP-1 Receptor Agonists (GLP-1ra) available?

Common GLP-1 receptor agonists include Ozempic (semaglutide), Trulicity (dulaglutide), Bydureon (exenatide extended-release), and Victoza (liraglutide).


Comments


bottom of page